Showing results (1011-1020 of 2,816) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|September 16, 2024
Transitioning from Self-Monitoring of Blood Glucose to Continuous Glucose Monitoring in Combination with a mHealth App Improves Glycemic Control in People with Type 1 and Type 2 DiabetesJosip Zivkovic, Michael Mitter, Delphine Theodorou, et al.Diabetes Technology & Therapeutics|November 7, 2024
Effect of Interrupting Prolonged Sitting with Frequent Activity Breaks on Postprandial Glycemia and Insulin Sensitivity in Adults with Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Therapy: A Randomized Crossover Pilot TrialRobyn Larsen, Frances Taylor, Paddy C Dempsey, et al.Diabetes Technology & Therapeutics|November 6, 2024
Evaluation of an Automated Priming Bolus for Improving Prandial Glucose Control in Full Closed Loop DeliveryMarcela Moscoso-Vasquez, Patricio Colmegna, Charlotte Barnett, et al.Diabetes Technology & Therapeutics|February 14, 2025
Omnipod5 Real-World Data from the First Pediatric Users' Universal Coverage Under the UK National Health ServiceSze May Ng, Zoe Tattersall, Violet Swain, et al.Diabetes Technology & Therapeutics|February 24, 2025
The Association of Time-in-Range and Time-in-Tight-Range with Retinopathy Progression in the Virtual Diabetes Control and Complications Trial Continuous Glucose Monitoring DatasetBenjamin Lobo, Lauren Kanapka, Boris P Kovatchev, et al.Diabetes Technology & Therapeutics|August 31, 2006
An integrated graphic scheme for the display of insulin prescription and blood glucose informationMatthew I KimDiabetes Technology & Therapeutics|February 24, 2007
Comparison of standard (self-directed) versus intensive patient training for the human insulin inhalation powder (HIIP) delivery system in patients with type 2 diabetes: efficacy, safety, and training measuresJulio Rosenstock, Masako Nakano, Bernard L Silverman, et al.Diabetes Technology & Therapeutics|February 24, 2007
Effect of standard (self-directed) training versus intensive training for Lilly/Alkermes human insulin inhalation powder delivery system on patient-reported outcomes and patient evaluation of the systemRisa P Hayes, Masako Nakano, Douglas Muchmore, et al.Diabetes Technology & Therapeutics|November 18, 2006
A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitusAnthony L McCall, Daniel J Cox, John Crean, et al.Diabetes Technology & Therapeutics|November 18, 2006
Bedside monitoring of blood beta-hydroxybutyrate levels in the management of diabetic ketoacidosis in childrenArleta Rewers, Kim McFann, H Peter ChasePageof 282